Yawer Nensey, MD
Gastroenterology · Zephyrhills, FLNPI 1861459166
Payments from drug & device makers
Across 268 payments — averaging $22.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Echosens North America, Inc.$646
- Johnson & Johnson$605
- Sanofi$493
- Takeda Pharmaceuticals U.S.A., Inc.$435
- Pfizer$381
- plus $2K from 22 others
What the payments were for
- Consulting fees$280%
- Travel & lodging$64611%
- Food & beverage$5,18984%
- Education$2925%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 88 | $1,584 |
| Echosens North America, Inc. | 1 | $646 |
| Johnson & Johnson(3 entities) | 20 | $605 |
| Sanofi | 21 | $493 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $435 |
| Pfizer | 19 | $381 |
| Gilead | 13 | $366 |
| Bristol Myers Squibb | 15 | $241 |
| QOL Medical, LLC | 6 | $210 |
| Regeneron Healthcare Solutions, Inc. | 7 | $172 |
| Intercept Pharmaceuticals, Inc. | 6 | $133 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $126 |
| Madrigal Pharmaceuticals | 6 | $126 |
| Lucid Diagnostics Inc. | 6 | $107 |
| Lilly USA, LLC | 3 | $72 |
| Evoke Pharma, Inc. | 3 | $71 |
| UCB, Inc. | 4 | $57 |
| Redhill Biopharma Inc. | 3 | $52 |
| Celltrion USA Inc. | 2 | $51 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
| Romark Laboratories, LC | 5 | $32 |
| Nestle Healthcare Nutrition Inc. | 2 | $32 |
| Fujifilm Healthcare Americas Corporation | 1 | $32 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Axonics, Inc. | 1 | $21 |
| Ardelyx, Inc. | 1 | $19 |
| Braintree Laboratories, Inc. | 1 | $19 |
| Boston Scientific | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FibroScan$646
How this compares
$6,156 in reported general payments places this provider in the 60th percentile of 1,388 gastroenterology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexlansoprazole DrDexlansoprazole | 12 | $2,752 |
| Lubiprostone | 15 | $2,451 |
| Pantoprazole Sodium | 78 | $1,508 |
| Omeprazole | 58 | $1,289 |
| Sucralfate | 36 | $604 |
| Dicyclomine Hcl | 23 | $516 |
| Famotidine | 22 | $431 |
| Promethazine Hcl | 13 | $238 |
| Amitriptyline Hcl | 14 | $139 |
| Metoclopramide Hcl | 11 | $10 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Zephyrhills
- Tawfik ChamiZephyrhills$1.6M
- Howard SchwartzTavernier$38.8M
- Guy NeffSarasota$17.6M
- Syed LateefClermont$6.4M
- Jeffrey SchneiderCoral Springs$6M
- Zaid RanaMiami$5.4M
- David NelsonGainesville$5.2M
- Alan WeintraubTampa$4.7M
- Curtis FreedlandNew Port Richey$4.5M
- Paul HellsternCrystal River$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.